1. Home
  2. BSVN vs RCKT Comparison

BSVN vs RCKT Comparison

Compare BSVN & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bank7 Corp.

BSVN

Bank7 Corp.

HOLD

Current Price

$43.73

Market Cap

393.6M

Sector

Finance

ML Signal

HOLD

Logo Rocket Pharmaceuticals Inc.

RCKT

Rocket Pharmaceuticals Inc.

HOLD

Current Price

$3.75

Market Cap

428.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BSVN
RCKT
Founded
2004
1999
Country
United States
United States
Employees
N/A
299
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
393.6M
428.6M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
BSVN
RCKT
Price
$43.73
$3.75
Analyst Decision
Buy
Buy
Analyst Count
3
14
Target Price
$53.33
$29.12
AVG Volume (30 Days)
16.2K
1.9M
Earning Date
01-15-2026
02-26-2026
Dividend Yield
2.50%
N/A
EPS Growth
19.43
N/A
EPS
4.54
N/A
Revenue
$95,710,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.23
N/A
P/E Ratio
$9.50
N/A
Revenue Growth
11.45
N/A
52 Week Low
$32.49
$2.19
52 Week High
$50.26
$11.45

Technical Indicators

Market Signals
Indicator
BSVN
RCKT
Relative Strength Index (RSI) 60.46 55.32
Support Level $42.07 $3.47
Resistance Level $42.99 $3.98
Average True Range (ATR) 0.99 0.22
MACD 0.18 0.02
Stochastic Oscillator 95.60 55.80

Price Performance

Historical Comparison
BSVN
RCKT

About BSVN Bank7 Corp.

Bank7 Corp is a full-service commercial bank focused on providing customers with exceptional service and meeting their banking needs through a variety of commercial and retail financial services. It offers deposit banking products, including commercial deposit services, commercial checking, money market, and other deposit accounts, and retail deposit services such as certificates of deposit, money market accounts, checking accounts, negotiable order of withdrawal accounts, savings accounts, and automated teller machine access. etc. It generates revenues from interest income from financial instruments and non-interest income and service charges on deposit accounts.

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.

Share on Social Networks: